( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1053.8
1065.4
1354.2
1457.2
Total Expenditure
1073.6
1132
1550.8
1604.6
PBIDT (Excl OI)
-19.8
-66.59
-196.6
-147.4
Other Income
20.4
30.1
11.9
9.8
Operating Profit
0.60
-36.5
-184.7
-137.6
Interest
75.6
89.8
94.9
130.8
Exceptional Items
37.6
5.1
45.8
630.3
PBDT
-37.39
-121.2
-233.8
361.9
Depreciation
51.3
71.3
75.3
84.3
Profit Before Tax
-88.69
-192.5
-309.1
277.6
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-202
-153.2
-251.3
407.6
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-141.6
-153.2
-251.3
407.6
Minority Interest
NA
NA
NA
NA
Shares of Associates
19.5
39.8
81.2
-14.1
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-122.1
-113.4
-170.1
393.5
Equity Capital
48.2
48.2
48.2
48.2
Face Value (IN RS)
10
10
10
10
Calculated EPS
-25.33
-23.52
-35.29
81.63
Calculated EPS (Annualised)
-101.32
-94.10
-141.16
326.55
No of Public Share Holdings
1276601
1276601
1276601
1276601
% of Public Share Holdings
26.51
26.51
26.49
26.51
PBIDTM% (Excl OI)
-1.87
-6.25
-14.51
-10.11
PBIDTM%
0.05
-3.42
-13.63
-9.44
PBDTM%
-3.54
-11.37
-17.26
24.83
PBTM%
-8.41
-18.06
-22.82
19.05
PATM%
-19.16
-14.37
-18.55
27.97